DHR Latest Press Releases

-- November 4, 2026 --

Why the Next Edge in Antibody Discovery May Be What Labs Remember Globe Newswire 8:15 AM

Integrated DNA Technologies and Aldevron Launch New mRNA Solutions to Simplify Base and Prime Editing Business Wire 8:05 AM

-- November 2, 2026 --

Danaher to Present at UBS Global and Jefferies Global Healthcare Conferences PRNewswire 4:30 PM

-- October 21, 2026 --

Danaher Reports Third Quarter 2026 Results PRNewswire 6:01 AM

-- October 14, 2026 --

Danaher Collaborates with NVIDIA to Advance Autonomous Science PRNewswire 2:00 AM

-- October 12, 2026 --

Danaher Announces Appointments of Daniel Comas and Robert Hershberg to Board of Directors PRNewswire 4:25 PM

-- October 7, 2026 --

Danaher Accelerates Life Sciences Research with New AI-powered Autonomous Lab PRNewswire 7:00 AM

-- October 1, 2026 --

Julie Sawyer Montgomery Assumes Role as Danaher President and Chief Executive Officer PRNewswire 7:00 AM

-- September 22, 2026 --

Danaher Schedules Third Quarter 2026 Earnings Conference Call PRNewswire 4:16 PM

-- September 16, 2026 --

Integrated DNA Technologies and Aldevron Launch New Cas9 mRNA Solutions to Accelerate Path from Gene Editing Research to Development Business Wire 8:03 AM

-- September 15, 2026 --

Danaher Announces Quarterly Dividend PRNewswire 4:16 PM

-- August 3, 2026 --

Danaher Appoints Julie Sawyer Montgomery as President and Chief Executive Officer PRNewswire 4:15 PM

-- July 21, 2026 --

Danaher Reports Second Quarter 2026 Results PRNewswire 6:00 AM

-- July 14, 2026 --

Audax Private Equity and Linden Capital Partners Agree to Sell StatLab Medical Products to Leica Biosystems Business Wire 5:25 PM

-- July 3, 2026 --

Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders? PRNewswire 12:26 PM

-- June 29, 2026 --

Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa PRNewswire 8:30 AM

-- June 22, 2026 --

Danaher Schedules Second Quarter 2026 Earnings Conference Call PRNewswire 4:15 PM

Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM to Help Identify Respiratory Risk Sooner Business Wire 8:00 AM

-- June 10, 2026 --

Danaher Completes Acquisition of Masimo Corporation PRNewswire 8:56 AM

Market Data Delayed 15 Minutes